Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
Open Access
- 15 December 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 143 (12) , 4244-4249
- https://doi.org/10.4049/jimmunol.143.12.4244
Abstract
The capacity of BALB/c mice to acquire resistance to and eliminate intracellular visceral Leishmania donovani is T cell dependent, associated with a granulomatous tissue reaction, and correlates with the ability to secrete the macrophage-activating lymphokine, IFN-gamma. These responses appear by 4 wk after infection and are fully established by 8 wk. To examine the role of endogenous IFN-gamma, BALB/c mice were injected with anti-IFN-gamma mAb before and for 8 wk after infection. At 4 wk, mAb treatment inhibited the acquisition of resistance to L. donovani and abolished mature granuloma formation. Although liver parasite burdens in mAb-treated mice were fivefold higher than in controls at 8 wk, continually treated mice nevertheless began for form tissue granulomas and decreased their parasite loads by 50% from peak values. The levels of anti-IFN-gamma antibody in the serum of mice injected for 8 wk were appreciably reduced, thus raising the possibilities of either insufficient neutralization of endogenous IFN-gamma at this time point or a pathway independent of IFN-gamma. Although the role of IFN-gamma and the potential effect of an IFN-gamma-independent mechanism in the resolution of visceral infection remain to be defined, these results indicate that IFN-gamma plays a critical role in the early immune response that both optimally controls L. donovani infection and induces the tissue granuloma.This publication has 32 references indexed in Scilit:
- Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial ChallengeAnnals of Internal Medicine, 1988
- A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.The Journal of Immunology, 1986
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985
- Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.Proceedings of the National Academy of Sciences, 1985
- Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: Induction of microbicidal activity by Interferon-γCellular Immunology, 1985
- Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.The Journal of Immunology, 1985
- Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.The Journal of Immunology, 1985
- Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.The Journal of Experimental Medicine, 1983
- Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.Journal of Clinical Investigation, 1983
- Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.The Journal of Immunology, 1982